0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

A NEW GERMICIDE FOR USE IN THE GENITO-URINARY TRACT: "MERCUROCHROME-220":  PRELIMINARY REPORT OF EXPERIMENTAL AND CLINICAL STUDIES

HUGH H. YOUNG, M.D.; EDWIN C. WHITE, Ph.D.; ERNEST O. SWARTZ, M.D.
JAMA. 1919;73(20):1483-1491. doi:10.1001/jama.1919.02610460001001.
Text Size: A A A
Published online

During the past two years the research work in the laboratories of the James Buchanan Brady Urological Institute has been given over largely to the study of antiseptics with a view particularly to the development of drugs applicable to the genito-urinary tract. Attention was first directed to internal antiseptics, since Hinman1 had previously shown in our laboratories the questionable value of hexamethylenamin. Starting with the remarkable selective activity of the kidneys on phenolsulphonephthalein, as shown by the work of Abel and Rowntree2 and developed as a functional test in our clinic, we tried to attach other chemical agents to phenolsulphonephthalein and thus produce an effective internal urinary antiseptic. Some interesting drugs were produced and studied by Davis and one of us (E. C. W.3). The war interrupted these studies, but the urgent need of really effective antiseptics for local use in the genito-urinary tract induced us later

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();